Synlett 2014; 25(18): 2595-2598
DOI: 10.1055/s-0034-1379237
letter
© Georg Thieme Verlag Stuttgart · New York

A Base-Catalyzed Cascade Route to Phenolic 6-Cyanopurines via O-Alkylformamidoximes

Filipe M. Areias
Centro de Química, Universidade do Minho, Campus de Gualtar, 4710-057 Braga, Portugal   Fax: +351(253)604382   Email: fproenca@quimica.uminho.pt
,
M. Fernanda Proença*
Centro de Química, Universidade do Minho, Campus de Gualtar, 4710-057 Braga, Portugal   Fax: +351(253)604382   Email: fproenca@quimica.uminho.pt
› Author Affiliations
Further Information

Publication History

Received: 15 July 2014

Accepted after revision: 11 September 2014

Publication Date:
16 October 2014 (online)


Abstract

N-[1,2-Dicyano-2-(hydroxyphenylideneamino)vinyl]-O-alkylformamidoximes were prepared from the reaction of N-(2-amino-1,2-dicyanovinyl)-O-alkylformamidoximes with phenolic aldehydes. These compounds generated 2-hydroxyphenyl-4,5-dicyano-N-(N'-alkoxyformimidoyl)imidazoles in the presence of manganese oxide, whereas in triethylamine 6-cyano-8-hydroxy-phenylpurines were isolated. The reaction was followed by 1H NMR spectroscopy and a plausible mechanism is presented.

Supporting Information

 
  • References and Notes

  • 1 Tunçbilek M, Ateş-Alagöz Z, Altanlar N, Karayel A, Özbey S. Bioorg. Med. Chem. 2009; 17: 1693
  • 2 Roggen H, Charnock C, Burman R, Felth J, Larsson R, Bohlin L, Gundersen L. Arch. Pharm. Chem. Life Sci. 2011; 344: 50
  • 3 Rida S, Ashour F, El-Hawash S, El-Semary M, Badr M. Arch. Pharm. Chem. Life Sci. 2007; 340: 185
  • 4 Narayanasamy J, Pullagurla M, Sharon A, Wang J, Schinazi R, Chu C. Antiviral Res. 2007; 75: 198
  • 5 Chih Y, Kukla J. Bioorg. Med. Chem. Lett. 1991; 1: 531
  • 6 Booth B, Coster D, Proenca M. Synthesis 1988; 389
  • 7 Booth L, Dias M, Proenca M, Zaki M. J. Org. Chem. 2001; 66: 8436
  • 8 Mackay L, Hitchings G. J. Am. Chem. Soc. 1956; 78: 3511
  • 9 Miyashita A, Susuki Y, Ohta K, Higashino T. Heterocycles 1994; 39: 345
  • 10 Hayashi E, Shimida N, Miyashita A. Yakugaku Zasshi 1976; 96: 1370 ; Chem. Abstr. 1977, 86, 121295
  • 11 Yamane A, Matsuda M, Ueda T. Chem. Pharm. Bull. 1980; 28: 150
  • 12 Barlin G, Young A. J. Chem. Soc., Perkin Trans. 1 1972; 1269
  • 13 Giner-Sorolla A. Chem. Ber. 1968; 101: 611
  • 14 Schirra M, D’Aquino S, Cabras P, Angioni A. J. Agric. Food Chem. 2011; 59: 8531
  • 15 Booth B, Costa F, Pritchard R, Proença M. Synthesis 2000; 1269
  • 16 Sun S, Lou H, Gao Y, Fan P, Ma B, Ge W, Wang X. J. Pharm. Biomed. Anal. 2004; 34: 1117
  • 17 Sun S, Gao Y, Ling X, Lou H. Anal. Biochem. 2005; 336: 39
  • 18 Hamada Y, Shibata M, Sugiura T, Kato S, Shioiri T. J. Org. Chem. 1987; 52: 1252
  • 19 Booth B, Costa F, Mahmood Z, Pritchard R, Proença M. J. Chem. Soc., Perkin Trans. 1 1999; 1853
  • 20 Synthesis of (Z)-N-[1,2-Dicyano-2-(arylideneamino)-vinyl]-O-alkylformamidoximes (2); General Procedure: Toluenesulfonic acid (cat.) was added to a suspension of either 1a (3.31 mmol) or 1b (1.23–2.45 mmol) and the phenolic aldehyde (1.23–3.31 mmol, 1 equiv) in either MeOH, CH2Cl2–EtOH (10:1), or EtOH (2–7 mL). The reaction was complete after 15 min stirring on an ice bath, and the yellow solid was collected by filtration and washed with cold Et2O to afford products 2af. (Z)-N-[1,2-Dicyano-2-(2'-hydroxybenzylidenamino)-vinyl]-O-benzylformamidoxime (2a): Yield: 1.11 g (3.20 mmol, 97%); mp 183–185 °C. IR (NaCl): 3407, 3280, 2234, 2222, 1646, 1623, 1606, 1560, 1494, 1459, 1403 cm–1. 1H NMR (300 MHz, DMSO-d 6): δ (major tautomer: M) = 10.75 (s, 1 H), 9.33 (s, 1 H), 8.77 (s, 1 H), 7.66 (d, J = 7.80 Hz, 1 H), 7.64 (s, 1 H), 7.30–7.45 (m, 6 H), 6.98 (d, J = 8.40 Hz, 1 H), 6.83 (t, J = 7.80 Hz, 1 H), 5.08 (s, 2 H); δ (minor tautomer: m) = 10.58 (s, 1 H), 8.73 (s, 1 H), 8.24 (s, 1 H), 4.98 (s, 2 H); Ratio M/m = 7:1. 13C NMR (300 MHz, DMSO-d 6): δ (major tautomer: M) = 159.53, 157.63, 137.25, 136.94, 135.06, 128.34, 128.12, 127.95, 127.72, 120.58, 119.72, 117.89, 116.86, 113.23, 112.49, 112.31, 75.48; δ (minor tautomer: m) = 159.06, 156.70, 134.50, 129.24, 128.29, 128.21, 127.79, 121.00, 119.44, 116.56, 75.29. Anal. Calcd for C19H15N5O2: C, 66.1; H, 4.4; N, 20.3. Found: C, 66.2; H, 4.4; N, 20.1. Synthesis of 2-Aryl-4,5-dicyano-N-(N'-alkoxyformi-midoyl)imidazoles (3); General Procedure: A solution of 2 (0.25 g, 0.72 mmol) in THF was combined with MnO2 (25–50 equiv). The reaction was complete after 1–29 days heating at reflux and the mixture was filtered through glass fiber paper. The solvent was concentrated under reduced pressure and a yellow solid precipitated by addition of chloroform and n-hexane. The solid was filtered to afford products 3af. 4,5-Dicyano-2-(2′-hydroxyphenyl)-N-(N′-benzyloxifor-mimidoyl)imidazole (3a): Yield: 0.16 g (0.46 mmol, 64%); mp 171–174 °C. IR (NaCl): 3195, 3089, 3035, 2248, 2237, 1631, 1605, 1581, 1550, 1518, 1483, 1392 cm–1. 1H NMR (300 MHz, DMSO-d 6): δ = 11.00–15.00 (s, <1 H), 7.95 (d, J = 7.50 Hz, 1 H), 7.46 (s, 1 H), 7.24–7.42 (m, 6 H), 7.00 (d, J = 8.40 Hz, 1 H), 6.94 (t, J = 8.10 Hz, 1 H), 5.02 (s, 2 H). 13C NMR (300 MHz, DMSO-d6): δ = 155.51, 151.49, 142.72, 137.61, 131.73, 128.65, 128.33, 128.24, 127.87, 119.53, 116.43, 114.29, 112.12, 109.26, 75.42. Anal. Calcd for C19H13N5O2·0.1H2O: C, 66.0; H, 3,9; N, 20.3. Found: C, 66.0; H, 3.9; N, 20.1. 6-Cyano-8-(2'-hydroxyphenyl)purine (4a): Et3N (1.0 mL) was added to a suspension of 2a (0.10 g, 0.29 mmol) in MeCN (25 mL) leading to a red solution. The mixture was heated to reflux for 3 h, then the solvent was concentrated on a rotary evaporator. Addition of CH2Cl2 and n-hexane led to the formation of a yellow solid that was filtered to give 4a. Yield: 0.04 g (0.17 mmol, 58%); mp >300 °C (dec.). IR (NaCl): 3532, 3280, 2244, 1665, 1625, 1604, 1585, 1514, 1398 cm–1. 1H NMR (300 MHz, DMSO-d 6): δ = 10–15 (s, 2 H), 9.00 (s, 1 H), 8.12 (dd, J = 7.80, 1.50 Hz, 1 H), 7.45 (dt, J = 7.80, 1.50 Hz, 1 H), 7.06 (d, J = 7.80 Hz, 1 H), 7.01 (dt, J = 7.80, 0.90 Hz, 1 H). 13C NMR (300 MHz, DMSO-d 6): δ = 158.57, 158.40, 155.91, 151.93, 134.08, 133.64, 128.63, 125.20, 119.74, 117.40, 114.70, 112.24. Anal. Calcd for C12H7N5O·0.9H2O: C, 56.9; H, 3.5; N, 27.6. Found: C, 57.2; H, 3.5; N, 27.3. 6-Cyano-8-(3′-hydroxyphenyl)purine (4b): Et3N (0.52 mL) was added to a solution of 2e (0.10 g, 0.37 mmol) in DMSO (0.5 mL) and the mixture was stirred at r.t. for 4 days. A white solid was formed after addition of CHCl3 and n-hexane. The product was filtered and washed with n-hexane to give 4b. Yield: 0.06 g (0.27 mmol, 72%); mp >300 °C (dec.). IR (NaCl): 3404, 3153, 2243, 1625, 1613, 1598, 1583, 1527, 1406 cm–1. 1H NMR (300 MHz, DMSO-d 6): δ = 9.91 (s, >1 H, NH), 8.98 (s, 1H), 7.75 (d, J = 1.20 Hz, 1 H), 7.74 (d, J = 7.80 Hz, 1 H), 7.41 (t, J = 7.80 Hz, 1 H), 7.01 (dt, J = 8.10, 1.80 Hz, 1 H). 13C NMR (300 MHz, DMSO-d 6): δ = 158.45, 157.94, 156.78, 151.77, 135.49, 130.39, 129.38, 126.03, 119.41, 118.67, 114.88, 114.41. Anal. Calcd for C12H7N5O·0.6H2O: C, 58.0; H, 3.4; N, 28.2. Found: C, 58.3; H, 3.7; N, 28.0. 6-Cyano-8-(4′-hydroxyphenyl)purine (4c): Et3N (1.50 mL) was added to a suspension of 2f (0.10 g, 0.37 mmol) in MeCN (9 mL), leading to an orange solution. After 3 h heating to reflux, the solvent was concentrated on a rotary evaporator to give a yellow solid that was filtered and washed with Et2O to give 4c. Yield: 0.06 g (0.25 mmol, 67%); mp >300 °C (dec.). IR (NaCl): 3454, 3379, 3144, 2236, 1656, 1615, 1592, 1563, 1481, 1437 cm–1. 1H NMR (300 MHz, DMSO-d 6): δ = 13.50–15.00 (s, 1 H), 10.45 (s, 1 H), 8.93 (s, 1 H), 8.17 (d, J = 8.70 Hz, 2 H), 6.97 (d, 2 H, J = 8.70 Hz). 13C NMR (300 MHz, DMSO-d 6): δ = 161.60, 158.35, 156.69, 151.46, 144.83, 130.12, 124.93, 118.52, 116.18, 115.01. HRMS: m/z [M + H]+ calcd for C12H7N5O: 238.0684; found: 238.0732.